Clinical considerations associated with CPX-351 therapy for high-risk acute myeloid leukemia. Onaka T, Imada K. Leuk Lymphoma 2026 Jul 25:1-4. doi: 10.1080/10428194.2026.2704267.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Onaka T, Imada K. Clinical considerations associated with CPX-351 therapy for high-risk acute myeloid leukemia. Leuk Lymphoma 2026 Jul 25:1-4. doi: 10.1080/10428194.2026.2704267.
PMID: 42502068